DAWN LEGGON: Open Payments
NPI 1770650152 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 46 payments from 18 companies in 2025. Trend: 2023 $1,161 · 2024 $1,054 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $256 |
| Novo Nordisk Inc | 9 | $177 |
| Amgen Inc. | 6 | $94 |
| E.R. Squibb & Sons, L.L.C. | 1 | $93 |
| PFIZER INC. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $27 |
| Dynavax Technologies Corporation | 1 | $23 |
Products named: AIRSUPRA, Ozempic, FARXIGA, COBENFY, Kerendia, REPATHA, Wegovy, OTEZLA.
Industry payments across FL — which companies pay providers there.
